333

VAXCELL-BIO

No trades
See on Supercharts

323990 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Vaxcell-Bio Therapeutics develops anti-cancer therapeutics. It specializes in immune cell therapy. The company was founded by Lee Jae-Jung on February 18, 2010 and is headquartered in Hwasun-gun, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

323990 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company